--- a
+++ b/clusters/9knumclustersv2/clust_1184.txt
@@ -0,0 +1,13 @@
+Patients with chronic active hepatitis or cirrhosis. If positive hepatitis serology, the study chair may deem the patient eligible based on the results of liver biopsy.
+Evidence of either cirrhosis or stage - liver fibrosis in patients with chronic hepatitis C or positive hepatitis C serology
+Evidence of either cirrhosis or stage - liver fibrosis in patients with chronic hepatitis C or positive hepatitis C serology
+Evidence of either cirrhosis or stage - liver fibrosis in patients with chronic hepatitis C or positive hepatitis C serology
+Evidence of either cirrhosis or stage - liver fibrosis in patients with chronic hepatitis C or positive hepatitis C serology
+Evidence of either cirrhosis or stage - liver fibrosis in patients with chronic hepatitis C or positive hepatitis C serology
+Evidence of either cirrhosis or stage - liver fibrosis in patients who either show chronic hepatitis C or positive hepatitis C serology
+Patients with chronic active hepatitis or cirrhosis; if positive hepatitis serology, the study chair may deem the patient eligible based on the results of liver biopsy
+Evidence of either cirrhosis or stage - liver fibrosis in patients with chronic hepatitis C or positive hepatitis C serology
+Evidence of either cirrhosis or stage - liver fibrosis in patients with chronic hepatitis C or positive hepatitis C serology.
+Patients with chronic active hepatitis or cirrhosis; if positive hepatitis serology, the study chair may deem the patient eligible based on the results of liver biopsy
+Evidence of either cirrhosis or stage - liver fibrosis in patients with chronic hepatitis C or positive hepatitis C serology
+Evidence of either cirrhosis or stage - liver fibrosis in patients with chronic hepatitis C or positive hepatitis C serology